Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03109197 · ClinicalTrials.gov registry record

Sudden Unexplained Death in Childhood (SUDC) Registry

A clinical trial of Sudden Unexplained Death Syndrome and Sudden Unexplained Death in Childhood, sponsored by NYU Langone Health.

Recruiting
Registry status
1,600
Enrollment target
1
Study location

NCT03109197 is a study of Sudden Unexplained Death Syndrome and Sudden Unexplained Death in Childhood that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 1,600 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03109197, a study of Sudden Unexplained Death Syndrome and Sudden Unexplained Death in Childhood, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
1,600 participants
Enrollment target
1
Study location

Study Summary

The purpose is to increase the understanding of the characteristics, circumstances, medical histories and pathologies of children from ages 11 months through 18 years who have died suddenly and unexpectedly, and in some instances, without explanation. The SUDC Registry and Research Collaborative will analyze cases of sudden unexpected deaths in these children to understand risk factors and causes, and develop preventative measures.

Interventions

  • OTHER Biospecimin Collection

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 1,600 participants
Start Date 2014-10-01
Est. Completion 2028-11-30

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03109197

The ClinicalTrials.gov registry entry for NCT03109197 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sudden Unexplained Death Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Biospecimin Collection is the first listed.

NCT03109197 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03109197 about?

NCT03109197 is a clinical study titled "Sudden Unexplained Death in Childhood (SUDC) Registry". The purpose is to increase the understanding of the characteristics, circumstances, medical histories and pathologies of children from ages 11 months through 18 years who have died suddenly and unexpectedly, and in some instances, without explanation. The SUDC Registry and Research Collaborative wil...

What is the current status of trial NCT03109197?

This trial is currently recruiting. The enrollment target is 1,600 participants. The study started on 2014-10-01. Estimated completion is 2028-11-30.

What conditions does trial NCT03109197 study?

This clinical trial studies the following conditions: Sudden Unexplained Death Syndrome, Sudden Unexplained Death in Childhood.

What interventions are being tested in trial NCT03109197?

The interventions under investigation include: Biospecimin Collection (OTHER).

Who is sponsoring clinical trial NCT03109197?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03109197 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.